The use of non-approved peptides or the use of approved peptides for conditions other than what they were approved for is known as "off-label" use
Slide from Katherine Tuttles presentation, during FLOW session, 61st European Renal Association Congress Conclusion The FLOW trial showed that semaglutide significantly decreased the risk of progression of kidney disease in T2DM, without significant increases in serious adverse events
Consult with our qualified healthcare professionals to explore how peptide therapy can be an integral part of your wellness journey
Biological activities of angiotensin II(16) hexapeptide and angiotensin II(17) heptapeptide in man
Bigelow's Lavender Salve has been a favorite since the early days, due to its ability to care for lips and beautify skin
315 In preliminary research, six overweight women treated with 250 mg Coleus forskohlii extract, standardized to contain 10% forskolin, twice daily for eight weeks lost an average of 10 pounds of body weight and 8% of body fat
